Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Impact of a Sexology Consultation on Disease Control of Type 2 Male Diabetics With Erectile Dysfunction

N/AUnknownNCT02899572
Centre Hospitalier Universitaire de la Réunion64 enrolled

Overview

Erection disorders constitute the first sign of vascular injury in type 2 diabetes patients. The important frequency of these disorders and their consequences in term of quality of life have a strong contrast with the actual interest showed for them by the medical community. Natural evolution of the disease and its management make that these disorders often occur little time after a therapeutic change. As a consequence, patients often accuse their medication to be responsible for the appearance of these disorders. This confusion, associated to false believes that may have the patients on their disease or their treatment, often leads to treatment discontinuation which has a deleterious effect on the disease evolution. Educational therapy programs showed a positive impact on therapeutic adherence. Increasing patients' knowledge on their disease and treatments increases their therapeutic adherence and makes it easier to balance diabetes and therefore limits complications appearance. Educational therapy programs concern today the disease, its process, its evolution, its treatments, their efficacy, their adverse effects but erection disorders are not specifically addressed. This study aims to evaluate the impact of a sexology consultation on diabetes balance measured via HbA1c rate. This consultation aims at precising this particular symptom of erection disorders, without any medicine prescription. The aim is to explain to patients the different links between their symptoms, diabetes, medicines and themselves.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

64

Conditions

Erectile DysfunctionType 2 Diabetes

Interventions

Sexology consultationPROCEDURE

a sexology consultation is planned in the 15 days after inclusion

Eligibility

Sex: MALEMin age: 18 YearsMax age: 65 Years
Medical Language ↔ Plain English
Inclusion Criteria: * type 2 diabetic male medically treated * aged from 18 to 65 years old included * having issue obtaining or maintaining an erection allowing a satisfying sexual intercourse * hospitalised or followed in consultation in one of the 2 participating sites Exclusion Criteria: * treated by a medicine which could be responsible for the erectile disorders (beta-blockers, central anti-hypertensive drugs, antialdosterones) * presenting another disease which could be responsible for the erectile disorders (neurological, hormonal, vascular, psychiatric diseases) * treated by an insulin pump

Locations (1)

Centre Hospitalier Gabriel Martin

Saint-Paul, France

RECRUITING

Outcomes

Primary Outcomes

Measurement of HbA1c according to the randomisation group

Time frame: 3 months after inclusion

Central Contacts

Julie DUTET, PharmD, PhD

CONTACT

+33262905282julie.dutet@chu-reunion.fr

Céline REGNIER, MD

CONTACT

regnier.c@ch-gmartin.fr
Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.